Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
What they do
Slope provides clinical trial execution software that manages the supply chain and biospecimen lifecycle. The company assists research sponsors, clinical research organisations, and clinical sites in collaborating on inventory, sample tracking, and protocol adherence to reduce trial operational errors.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Trial administration
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- San Francisco, United States
- Region
- North America
- Founded
- 2018
- Total funding
- $20M raised
Notable investors: New Enterprise Associates, Insight Partners, Alexandria Venture Investments.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Oracle and AstraZeneca: Bringing Clinical Trials Closer to Care
Dr. Dereck Mush, MD, MBA
Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA